SCHEMBL2278646

SCHEMBL2278646

CC(C)(C=O)c1cccc2c1OCO2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 1/20 0.39
ABCG2 Q9UNQ0 1/20 0.38
MAOB P27338 4/20 0.37
ALDH1A1 P00352 3/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
POLB P06746 2/20 0.35
PKM P14618 1/20 0.34
TSHR P16473 1/20 0.34
AOC3 Q16853 4/20 0.33
MGAM O43451 1/20 0.33
AMY1A P0DUB6 1/20 0.33
GAA P10253 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
LMNA P02545 2/20 0.33
HPGD P15428 2/20 0.33
MAPK1 P28482 1/20 0.32
KDM4E B2RXH2 1/20 0.32
EED O75530 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7416843 0.81 ABCG2 (0.41) GSK3BABCG2MAOBALDH1A1HSD17B10
SCHEMBL762016 0.80 ABCG2 (0.44) GSK3BABCG2MAOBALDH1A1TDP1
SCHEMBL3536675 0.77 ABCG2 (0.41) GSK3BABCG2MAOBALDH1A1POLB
SCHEMBL3819757 0.77 ABCG2 (0.41) GSK3BABCG2MAOBALDH1A1POLB
SCHEMBL14521256 0.75 ABCG2 (0.39) GSK3BABCG2MAOBALDH1A1POLB
SCHEMBL3531222 0.74 NR3C1 (0.38) GSK3BMAOBAOC3MGAMAMY1A
SCHEMBL161792 0.72 GSK3B (0.54) GSK3BABCG2MAOBALDH1A1HSD17B10
SCHEMBL29706697 0.72 GSK3B (0.54) GSK3BABCG2MAOBALDH1A1HSD17B10
SCHEMBL19738334 0.72 EED (0.37) GSK3BABCG2MAOBALDH1A1POLB
SCHEMBL10915836 0.72 ABCG2 (0.43) GSK3BABCG2MAOBPOLBPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160303019-A1 TOPICAL SKIN CARE FORMULATION MARY KAY INC. 2016-10-20 US claimed
US-9402794-B2 Topical skin care formulation MARY KAY INC. (US) 2016-08-02 US claimed
US-8318222-B2 Topical skin care formulation MARY KAY, INC. (US) 2012-11-27 US claimed
US-20110206793-A1 TOPICAL SKIN CARE FORMULATION MARY KAY INC. (US) 2011-08-25 US claimed
US-20240157177-A1 COSMETIC COMPOSITIONS AND USES THEREOF ALLUSTRA TECHNOLOGIES LLC 2024-05-16 US disclosed
US-11918833-B2 Cosmetic compositions and uses thereof MARY KAY INC. (US) 2024-03-05 US disclosed
US-11344751-B2 Cosmetic compositions and uses thereof MARY KAY INC. (US) 2022-05-31 US disclosed
CN-108697631-B Cosmetic composition and use thereof 玫琳凯有限公司 2022-04-26 CN disclosed
EP-3432859-B1 COSMETIC COMPOSITIONS AND USES THEREOF MARY KAY INC (US) 2021-07-14 EP disclosed
US-20210146168-A1 COSMETIC COMPOSITIONS AND USES THEREOF ALLUSTRA TECHNOLOGIES LLC 2021-05-20 US disclosed
US-10912956-B2 Cosmetic compositions and uses thereof MARY KAY INC. (US) 2021-02-09 US disclosed
EP-3432859-A1 COSMETIC COMPOSITIONS AND USES THEREOF Mary Kay, Inc. (US) 2019-01-30 EP disclosed
EP-2300590-B1 METHOD OF REDUCING VISCOSITY OF CONCENTRATED LIQUID CLEANSERS BY SELECTION OF PERFUME COMPONENTS UNILEVER PLC (GB) 2016-11-16 EP disclosed
US-20160303019-A1 TOPICAL SKIN CARE FORMULATION MARY KAY INC. 2016-10-20 US disclosed
US-9402794-B2 Topical skin care formulation MARY KAY INC. (US) 2016-08-02 US disclosed
US-20130156711-A1 TOPICAL SKIN CARE FORMULATION MARY KAY INC. (US) 2013-06-20 US disclosed
US-8318222-B2 Topical skin care formulation MARY KAY, INC. (US) 2012-11-27 US disclosed
US-20110206793-A1 TOPICAL SKIN CARE FORMULATION MARY KAY INC. (US) 2011-08-25 US disclosed
US-20090312223-A1 Method of Controlling Structure and Rheology of Low Active Liquid Cleansers by Selecting Perfume Components CONOPCO, INC., D/B/A UNILEVER (US) 2009-12-17 US disclosed
US-20090312224-A1 Method of Reducing Viscosity of Concentrated Liquid Cleansers by Selection of Perfume Components CONOPCO, INC., D/B/A UNILEVER (US) 2009-12-17 US disclosed